Sarcoma di Ewing extra scheletrico: valutazione dei fattori prognostici clinico-patologici e della risposta alle terapie

Title

Code

RETRO-EES

Type

Osservazionale

Start Year

2022

Status

Terminato

Principal Investigator

051-6366267

giuseppe.bianchi@ior.it

Bianchi Giuseppe, MD

3rd Orthopaedic and Traumatologic Clinic prevalently Oncologic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica III a prevalente indirizzo Oncologico

Director

Donati Davide Maria, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio clinico prot. RETRO-EES

Tuesday 19 July 2022, 15:17

PG0003929_2022_prot. RETRO-EES.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Sarcoma di Ewing extra scheletrico: valutazione dei fattori prognostici clinico-patologici e della risposta alle terapie

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Sarcoma di Ewing extra scheletrico: valutazione dei fattori prognostici clinico-patologici e della risposta alle terapie

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in